INTRODUCTION {#omy086s1}
============

The incidence of acute bacterial prostatitis involves \~10% of all cases of prostatitis \[[@omy086C1]\]. The incidence in the general population is 1--2%, with an increase to over 3% in asymptomatic HIV-positive patients \[[@omy086C2]\]. It generally affects men between the ages of 20 and 40, with an additional peak in men \>60 years old \[[@omy086C3]\].

CASE REPORT {#omy086s2}
===========

A 44-year-old male with a significant past medical history of nephrolithiasis and well-controlled HIV, presented to the emergency department (ED) with the chief complaint of left flank pain, abdominal pain and painful ejaculation for 5 days. He stated the left flank pain radiated into his left lower abdomen and into his left testicle. The pain was described as achy to sharp in nature. Associated symptoms included nausea, vomiting, decreased appetite, subjective fever and chills. These symptoms felt different than his prior ureteral stone. The only thing different that the patient noted was utilizing a prostate vibrator for the first time over the course of the previous week.

Vitals on arrival to the ED: 101.2 °F, blood pressure 92/54 mmHg, respiratory rate of 21 breaths/min, weight of 94.5 kg and SpO2 98% on room air. On physical exam the patient was in distress secondary to the pain, diaphoretic and appeared ill. Oral mucosa was dry. Cardiopulmonary exam revealed sinus tachycardia, no murmur, with clear lungs bilaterally. Abdominal exam was notable for left costovertebral angle tenderness, left upper and lower abdominal tenderness to palpation with voluntary guarding. Genitourinary exam revealed tenderness to palpation along the left inguinal canal and left epididymitis. There was no clinical evidence for abscess, cellulitis or crepitus to the groin. The remaining physical exam was negative for any acute process. Sepsis protocol was initiated, two peripheral IVs were placed, urine/blood cultures were taken, laboratory evaluation started and fluid resuscitation initiated with normal saline 30 mL/kg IV bolus.

A complete blood count revealed a leukocytosis of 18.2 with neutrophil predominance, hemoglobin of 11.6 and a platelet level of 220 bil/L. Basic metabolic panel was notable for a pre-renal azotemia with a blood urea nitrogen (BUN) of 27 mg/dL, creatinine of 1.3 mg/dL and a blood glucose of 130. Hepatic function panel was unremarkable. Lactic acid of 3.2 (1.5 two hours later). Urinalysis was notable for 2+ blood, +nitrites, 3+ leukocyte esterase, \>50 WBCs, 3+ bacteria and 25--50 RBCs. C-reactive protein 7.1 (0.0--0.8 mg/dL). The rest of the laboratory evaluation was unremarkable. Given the patient's history of an immunocompromised state secondary to HIV, high-risk sexual behavior and recent prostate manipulation secondary to a prostate vibrator, there was concern for acute bacterial prostatitis and the patient was started on ceftriaxone and gentamicin.

Ultrasound of the scrotum with Doppler revealed a prominent epididymis with increased vascularity as compared to the right, with the addition of a small left hydrocele with scattered internal debris. There was no evidence for compromised arterial flow or abscess formation. Sonographic findings were consistent with a left epididymitis and an associated left hydrocele (Fig. [1](#omy086F1){ref-type="fig"}A). CT of the abdomen/pelvis without contrast was performed revealing left-sided peri-ureteral fat stranding, prominent left seminal vesicle, with infiltrative fat stranding predominantly centered around the left hemi-pelvis with multiple prominent pelvic lymph nodes up to 8.1 mm within the right iliac chain including prominent inguinal lymph nodes up to 6.5 mm (Fig. [1](#omy086F1){ref-type="fig"}B and C). The prostate is top-normal in size at 5 cm (Fig. [1](#omy086F1){ref-type="fig"}D). Sonographic findings were consistent with inflammatory changes within the left hemi-pelvis with prominence of the left seminal vesicle and prostate. These findings were favored to be secondary to an infectious process such as prostatitis. The peri-ureteral fat stranding was thought to be reactive to prostatitis.

![Ultrasound of the scrotum with Doppler revealed a prominent epididymis with increased vascularity in addition to a small left hydrocele. Sonographic findings were consistent with a left epididymitis and an associated left hydrocele (**a**). CT of the abdomen/pelvis without contrast was performed revealing left-sided peri-ureteral fat stranding, a prominent left seminal vesicle, with infiltrative fat stranding predominantly centered around the left hemi-pelvis with multiple prominent pelvic lymph nodes up to 8.1 mm within the right iliac chain including prominent inguinal lymph nodes up to 6.5 mm (**b** and **c**). The prostate is top-normal in size at 5 cm (**d**). Sonographic findings were consistent with inflammatory changes within the left hemi-pelvis with prominence of the left seminal vesicle and prostate favored to be secondary to prostatitis.](omy086f01){#omy086F1}

Status post 30 mL/kg of fluid resuscitation, the patient remained hypotensive with a MAP \< 65, resulting in placement of a central venous catheter and initiation of inotropic medication. He was admitted to the intensive care unit for further management. Urine and blood cultures grew *Escherichia coli* that was pansusceptible. Further testing for *Chlamydia trachomatis* and *Neisseria gonorrhoeae* DNA was negative. The patient progressed well. By Day 3, he was off inotropic medication, remained hemodynamically stable, and was tolerating a regular diet. He will need a total of 30 days of antibiotics to prevent chronic prostatitis. By Day 4, he was deemed stable and was discharged with cefuroxime. At his 1-month follow-up, the patient is progressing well and denied any complaints.

DISCUSSION {#omy086s3}
==========

The entry of bacteria into the prostate usually occurs via the urethra, in which case bacteria migrate from the urethra, to the bladder and to the prostatic ducts \[[@omy086C4]\]. It is not uncommon given intraprostatic reflux of urine to see a concomitant infection of the epididymis \[[@omy086C5]\]. Other mechanisms of transfer of microorganisms can occur by direct inoculation during transurethral manipulation or a transrectal prostate biopsy \[[@omy086C5]\]. The majority of cases are caused by intraprostatic reflux or ascending urethral infections. Common risk factors include benign prostatic hypertrophy, high-risk sexual behavior, genitourinary infections (epididymitis, urethritis, orchitis, urinary tract infection), immunocompromised states, phimosis, urethral stricture and prostate manipulation (transurethral surgery, transrectal prostate biopsy, catheterizations and cystoscopy) \[[@omy086C1], [@omy086C7]\]. A rare, but known risk factor, includes the use of prostate vibrator. Our patient had multiple risk factors for the development of acute bacterial prostatitis, including his underlying immunocompromised state, a urinary tract infection and left-sided epididymitis. Clinical research has shown that prostatic massage could potentially be a trigger of septic shock in these immunocompromised patients \[[@omy086C8]\]. In our patient, we hypothesize the new use of a prostate vibrator was the potential turning point in the patient becoming systemically ill, requiring IV antibiotics and admission to the ICU.

Common presenting symptoms to the ED will include irritative symptoms (dysuria, urgency and frequency) and obstructive symptoms (straining to urinate, weak stream, hesitancy and incomplete voiding) \[[@omy086C1]\]. Patients may present with suprapubic abdominal pain, rectal pain or perineal pain. In addition, painful ejaculation, painful defecation and hematospermia are also frequently encountered \[[@omy086C1]\]. Systemic symptoms are common, however, few cases are reported in the literature of septic shock secondary to acute bacteria prostatitis.

Acute bacterial prostatitis can be caused by various uropathogens, especially gram-negative bacteria, although infection can be caused with atypical organisms and gram-positive bacteria as well \[[@omy086C3]\]. *Escherichia coli* is the most common agent, ranging from 55% to 88% of cases. Other pathogens include *Proteus* species (3--6%), *Pseudomonas aeruginosa* (3--7%), other Enterobacteriaceae species like *Klebsiella*, *Serratia* and *Enterobacter* (3--11%) \[[@omy086C5]\]. In sexually active men, *Neisseria gonorrhoeae* and *Chlamydia trachomatis* are known causes of acute bacterial prostatitis. However, \<10% of patients that are diagnosed with acute bacterial prostatitis will have a proven bacterial infection \[[@omy086C2]\].

The most common complications arising from acute bacterial prostatitis include urinary retention, chronic bacterial prostatitis, prostatic abscess, bacteremia and metastatic infection to the spine \[[@omy086C5]\]. In patients that fail to improve clinically on antibiotics, they should undergo a CT or transrectal ultrasound to identify a possible prostatic abscess.

Overall, acute bacterial prostatitis is a clinical diagnosis. Urine culture and blood cultures are utilized to identify the causative bacterial organism \[[@omy086C3]\]. A digital rectal exam often reveals a tender and edematous prostate. This exam should be performed gently as it does increase the risk of bacteremia in immunocompromised patients. However, this exam was not performed on our patient given his septic shock presentation and recent use of a prostate vibrator. Laboratory evaluation often reveals a leukocytosis, bacteriuria and pyruria. C-reactive protein and erythrocyte sedimentation rate (ESR) are generally elevated and of little diagnostic utility. Clinical imaging studies like a CT are generally not indicated, unless there is clinical suspicion for another process, including a potential prostatic abscess, or ruling out other possible diagnoses. Diabetes and HIV have been shown to predispose patients to the development of a prostatic abscess with many of the symptoms mimicking acute bacterial prostatitis. Our patient presented with 5 days of symptoms, and while concern arose for acute bacterial prostatitis, the differential included ureteral stone/obstructive uropathy, emphysematous cystitis/pyelonephritis, benign prostatic hyperplasia, prostatic abscess, prostatic malignancy, enterovesical fistula or even a foreign body.

In one study involving 437 patients with acute bacterial prostatitis, 82% recovered without the development of complications at 3 months \[[@omy086C5]\]. Patients with a fever, positive blood cultures, white blood cell count \>18, BUN \> 19 mg/dL, age \>65 years old, prostatic abscess, immunocompromised and/or evidence of septic shock have all been associated with a higher morbidity and mortality \[[@omy086C7]\].

Treatment involves antimicrobials and supportive care. Hospitalization and intravenous antibiotics are generally reserved for those patients that are systemically ill. In general, patients can be managed as an outpatient, unless they cannot tolerate oral medications, presence of bacteremia and demonstrate severe sepsis/septic shock. The Department of Urology in Kosice, Slovak Republic, performed a retrospective study from 2003 to 2010 involving 192 patients with acute bacterial prostatitis. The sensitivity of various bacterial strains to common antibiotics is outlined in Table [1](#omy086TB1){ref-type="table"} \[[@omy086C9]\]. The difficulty in treatment is that few antimicrobial agents are able to penetrate the prostate gland to achieve sufficient enough concentrations to eliminate infection \[[@omy086C3]\]. For this reason, fluoroquinolones and cephalosporins are recommended as first-line treatment as they can achieve a high enough concentration within the prostate \[[@omy086C3]\]. Commonly used parenteral treatment regimens include levofloxacin 500 mg IV every 24 h, or ceftriaxone 2 gm IV every 24 h, with or without gentamicin 3--5 mg/kg daily \[[@omy086C3], [@omy086C6]\]. Sexually active men \<35 years old or those \>35 years old who are involved in high-risk sexual behavior require coverage for both *C. trachomatis* and *N. gonorrhoeae* \[[@omy086C5]\]. When the patient has improved clinically, they can be transitioned to oral medication, with an antibiotic course often recommended for at least 4 weeks \[[@omy086C3]\]. Multiple studies favor a longer treatment regimen secondary to limited antimicrobial penetration into the prostate and risk of progression to chronic bacterial prostatitis \[[@omy086C5], [@omy086C6]\]. Table 1:Sensitivity of various bacterial strains to common antibiotics in patients diagnosed with acute bacterial prostatitis. Figures in parentheses represent the total number (n) of cases identified in the retrospective study \[[@omy086C9]\]*E. coli* (*n* = 103) (%)*P. aeruginosa* (*n* = 10) (%)*Klebsiella* species (*n* = 9) (%)*S. epidermidis* (*n* = 6) (%)*P. mirabilis* (*n* = 4) (%)*Enterobacter* (*n* = 3) (%)*Enterococcus* (*n* = 3) (%)*S. haemolyticus* (*n* = 2) (%)Ampicillin73.8------50--33.3--Amoxicillin + Clavulanic acid86.4--33.3--75--66.6--Ampicillin + Sulbactam84.52033.383.375--66.650Piperacillin + Tazobactam95.210066.61007566.6--50Cefuroxime95.2--33.3--5033.3----Cefepime98.16033.31007566.6--100Ciprofloxacin925033.383.35066.6--50Gentamycin1008033.310075100--100Tobramycin98.18033.310075100--100Amikacin10080100100100100--100Imipenem100100100100100100--100Aztreonam98.110033.3100100----100Vancomycin------------100--

We present the case of a 44-year-old male who started using a prostate vibrator prior to his presentation to the ED where he was diagnosed with septic shock secondary to acute bacterial prostatitis. He ultimately required central venous access, arterial line placement, an inotropic agent and intensive care management. More research is needed in this area regarding prostate vibrator use in patients that are already immunocomprised with multiple risk factors for the development of acute bacterial prostatitis. To our knowledge, this is the first reported case in the literature of acute bacterial prostatitis secondary to a prostate vibrator.
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